The purpose of the current systematic review was to explore the state of evidence related to these lifestyle factors and ovarian and breast cancer risk among women with BRCA1/2 pathogenic germline gene variants, in order to determine the extent to which lifestyle recommendations should differ compared to the general population. The gene discussed is BRCA1; the disease is breast carcinoma.